Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

The Titanic and the Iceberg: prostate proton therapy and health care economics.

Zietman AL.

J Clin Oncol. 2007 Aug 20;25(24):3565-6. No abstract available.

2.

The potential of proton beam radiation therapy in prostate cancer, other urological cancers and gynaecological cancers.

Johansson B, Ridderheim M, Glimelius B.

Acta Oncol. 2005;44(8):890-5. Review.

PMID:
16332598
3.

"Boost" of proton therapy helps reduce prostate cancer recurrence.

Printz C.

Cancer. 2010 Apr 1;116(7):1619. doi: 10.1002/cncr.25161. No abstract available.

4.

Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer.

Vargas C, Fryer A, Mahajan C, Indelicato D, Horne D, Chellini A, McKenzie C, Lawlor P, Henderson R, Li Z, Lin L, Olivier K, Keole S.

Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):744-51. Epub 2007 Sep 27.

PMID:
17904306
5.

Proton therapy for prostate cancer: show me the CER!

Beyer DC.

Oncology (Williston Park). 2011 Jun;25(7):652, 656-7. Review. No abstract available.

6.

Should randomized clinical trials be required for proton radiotherapy?

Goitein M, Cox JD.

J Clin Oncol. 2008 Jan 10;26(2):175-6. doi: 10.1200/JCO.2007.14.4329. No abstract available.

7.

Physiologic reactions after proton beam therapy in patients with prostate cancer: significance of urinary autoactivation.

Shimizu M, Sasaki R, Miyawaki D, Nishimura H, Demizu Y, Akagi T, Suga D, Sakamoto H, Murakami M, Sugimura K, Hishikawa Y.

Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):580-6. doi: 10.1016/j.ijrobp.2009.02.085.

PMID:
19735884
8.

A comparison of proton therapy and IMRT treatment plans for prostate radiotherapy.

Dowdell SJ, Metcalfe PE, Morales JE, Jackson M, Rosenfeld AB.

Australas Phys Eng Sci Med. 2008 Dec;31(4):325-31.

PMID:
19239059
9.

Image guidance based on prostate position for prostate cancer proton therapy.

Vargas C, Wagner M, Indelicato D, Fryer A, Horne D, Chellini A, McKenzie C, Lawlor P, Mahajan C, Li Z, Lin L, Keole S.

Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1322-8. doi: 10.1016/j.ijrobp.2007.12.016. Epub 2008 May 28.

PMID:
18472365
10.

Proton therapy coverage for prostate cancer treatment.

Vargas C, Wagner M, Mahajan C, Indelicato D, Fryer A, Falchook A, Horne D, Chellini A, McKenzie C, Lawlor P, Li Z, Lin L, Keole S.

Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1492-501. doi: 10.1016/j.ijrobp.2007.09.001.

PMID:
18374228
11.

Proton therapy for prostate cancer. Although this is the most common use of proton therapy, controversy remains.

Printz C.

Cancer. 2009 Dec 15;115(24):5609-10. doi: 10.1002/cncr.24823. No abstract available.

12.

Advanced topics in evidence-based urologic oncology: economic analysis.

Vogel B, Gilbert SM, Boylston Herndon J, Dahm P.

Urol Oncol. 2011 Jul-Aug;29(4):454-61. doi: 10.1016/j.urolonc.2010.07.018. Review.

PMID:
21726796
13.

Back to the future: a proton pro/con.

Kavanagh BD, Raben D.

Oncology (Williston Park). 2011 Jun;25(7):657, 660, 662-3. Review. No abstract available.

14.

Proton therapy: expanding clinical indications.

Jones B, Price P.

Clin Oncol (R Coll Radiol). 2004 Aug;16(5):324-5. No abstract available.

PMID:
15341434
15.

Inter- and intrafractional movement-induced dose reduction of prostate target volume in proton beam treatment.

Yoon M, Kim D, Shin DH, Park SY, Lee SB, Kim DY, Kim JY, Pyo HR, Cho KH.

Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1091-102. doi: 10.1016/j.ijrobp.2007.11.031. Epub 2008 Jan 30.

PMID:
18234429
16.

Proton beam therapy for prostate cancer.

[No authors listed]

Technol Eval Cent Assess Program Exec Summ. 2011 Jun;25(10):1-4. No abstract available.

PMID:
21774163
17.

Records study finds no clear clinical benefit from proton therapy for prostate cancer.

Epstein K.

BMJ. 2012 Apr 17;344:e2767. doi: 10.1136/bmj.e2767. No abstract available.

PMID:
22511305
18.

Dose-volume differences for computed tomography and magnetic resonance imaging segmentation and planning for proton prostate cancer therapy.

Yeung AR, Vargas CE, Falchook A, Louis D, Olivier K, Keole S, Yeung D, Mendenhall NP, Li Z.

Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1426-33. doi: 10.1016/j.ijrobp.2008.03.031. Epub 2008 Aug 30.

PMID:
18762391
19.

Dosimetric changes resulting from patient rotational setup errors in proton therapy prostate plans.

Sejpal SV, Amos RA, Bluett JB, Levy LB, Kudchadker RJ, Johnson J, Choi S, Lee AK.

Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):40-8. doi: 10.1016/j.ijrobp.2008.08.042. Epub 2008 Dec 6.

PMID:
19058919
20.

Microscopic gold particle-based fiducial markers for proton therapy of prostate cancer.

Lim YK, Kwak J, Kim DW, Shin D, Yoon M, Park S, Kim JS, Ahn SH, Shin J, Lee SB, Park SY, Pyo HR, Kim DY, Cho KH.

Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1609-16. doi: 10.1016/j.ijrobp.2009.02.076.

PMID:
19616746
Items per page

Supplemental Content

Write to the Help Desk